This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Betsy Rezner
Director, Process & Assay Development at Fate Therapeutics Inc.

Agenda Sessions

  • Fate Therapeutic’s Off-the-shelf, iPSC-derived CAR T-Cell Cancer Immunotherapy Program

  • PANEL: Universal Cells: Is the Future for CGT Allogeneic ‘Off the Shelf’?